logo-loader
RNS
NMC Health PLC

NMC Health Plc - Cancellation of Listing

RNS Number : 9351K
NMC Health Plc
27 April 2020
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED IN ARTICLE 7 OF THE MARKET ABUSE REGULATION NO. 596/2014 ("MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

NMC Health plc

 

("NMC PLC" or the "Company")

 

CANCELLATION OF LISTING

London - April 27, 2020 - NMC Health PLC ("NMC Health") has requested that its ordinary shares be cancelled from listing on the premium segment of the Official List of the Financial Conduct Authority and from trading on the main market of the London Stock Exchange and for such cancellation to take effect as soon as possible.

Trading in the shares of NMC Health was  suspended on  27 February 2020 after the FCA agreed to the Group's request under Chapter 5 of the Listing for a temporary suspension of its shares to ensure the smooth operation of the market, while the Company looked to provide additional clarity to the market as to its financial position. On 10 March 2020, NMC Health announced its debt position was materially above the last reported numbers at around $5bn and on 23 March 2020 that debt was estimated to be around $6.6bn.

On 6 April 2020 NMC Health announced that it had been informed by lawyers acting for Abu Dhabi Commercial Bank PJSC ("ADCB") that ADCB had filed an application with the High Court of Justice, Business and Property Courts of England and Wales, Insolvency and Companies List (ChD) for the appointment of administrators in respect of the Company under paragraph 12(1)(c) of Schedule B1 to the Insolvency Act 1986 (the "Application"). The Application was successful, and Joint Administrators (the "Administrators") were appointed on 9 April 2020.

On appointment, the Administrators outlined that their primary objective was to ensure the continuity of patient care, through stability for staff and suppliers and financial security for NMC's operating companies. On 14 April 2020 a new Board was announced to oversee the implementation of corporate governance changes in the Group and oversee the work with the management teams in the individual NMC businesses.

Since then the Administrators, the management team and the Board have been working closely with all stakeholders on ensuring continuity of patient care.

Continued listing of the shares in NMC Health incurs significant cost and adds complexity in a situation where decisions need to be made quickly in partnership with the Group's stakeholders. Against this backdrop, the Administrators have concluded that delisting NMC Health's shares is appropriate.

The operating entities are unaffected by the delisting. NMC's hospitals, medical centres, care facilities and other operations in the Group continue to operate, under existing management, with patients continuing to be treated as they are currently.

Richard Fleming, Joint Administrator of NMC Health and Managing Director of Alvarez & Marsal, said:

"We are working at pace to ensure continuity of patient care, stability for staff and suppliers and financial security for NMC's operating companies. Delisting shares in NMC Health is the logical next step, given the situation we have inherited."

For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of NMC PLC by Richard Fleming, Joint Administrator.

ENDS

Media Enquiries:

UK/International

Headland Consultancy

Susanna Voyle                  +44 7980 894 557

Stephen Malthouse           +44 7734 956 201

Henry Wallers                   +44 7876 562 436

nmchealthgroup@headlandconsultancy.com 

Middle East

Hanover Communications Middle East

 Archie Berens                  +971 (0)55 559 7407

 Simone Elviss                  +971 (0)50 614 9383

 Omar Nasro                     +971 (0)55 471 0231

nmchealthcare@hanovercomms.com 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDZGZDVNRGGZG
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

4 min read